6/24/08- 7/1/08 Weekly Bird Flu Thread:WHO: Pakistan confirms new bird flu outbreak

JPD

Inactive
Pakistan confirms new bird flu outbreak

http://www.vnanet.vn/Home/EN/tabid/119/itemid/255252/Default.aspx

Hanoi (VNA) - Pakistan has confirmed a new outbreak of avian flu in poultry farm in North West Frontier province, culling some 2,000 chickens, foreign media said on June 23.

The virus was detected in Hamid poultry farm in the northwestern province of Swabi district after the owner of the farm informed that 4,000 chickens died in the past days.

Local Livestock and Dairy Development Department and the World Health Organization (WHO) officials said tests conducted in Islamabad laboratory proved the presence of deadly H5N1 strain of bird flu.-Enditem
 

JPD

Inactive
Unsold live chickens to be culled daily

http://www.news.gov.hk/en/category/healthandcommunity/080624/txt/080624en05003.htm

Unsold live chickens will banned from overnight stays at retail markets when chicken sales resume on July 2, while the Government will give more time for retailers, farmers, wholesalers and transport operators to consider a proposed compensation package to buy out their licences, Secretary for Food & Health Dr York Chow says.

Dr Chow told the media today the Executive Council's decision has taken into account the trade's views and the risks of avian flu. As the bureau has been unable to trace the source of bird flu detected earlier in markets, enhanced measures are needed at the retail level when sales of live and chilled chicken resumes.

The Food Business Regulation will be amended to ban live chickens from markets and fresh food shops between 8pm and 5am. All unsold live chickens at stalls will have to be culled before 8pm each day.

Food & Environmental Hygiene Department officers will conduct daily inspections from July 2 through early August to ensure the live poultry trade abides by the law. Violators will be liable to a $50,000 fine and six months in jail. Their licence or tenancy can also be cancelled.

Compensation offer worth $1b

On the proposed compensation for voluntarily terminating business, Dr Chow said retailers have an extra month - until July 24 - to consider whether to accept. Retailers, farmers, wholesalers and transport operators have three months, until September 24.

He noted the package is worth about $1 billion - about three times the value of that for the voluntary surrender scheme handed down in 2004-05. The Government has also agreed to scrap the shop area cap, to allow larger stalls to get more compensation.

Dr Chow said discussions with the live poultry trade will continue.

The Government will also offer an ex-gratia payment of $30 in compensation for each of the 400,000 chickens at local farms affected by the 21-day sale suspension, Dr Chow added.
 

JPD

Inactive
World is ‘unprepared for flu pandemic’

http://www.irishexaminer.com/irishe...-qqqm=world-qqqa=world-qqqid=65738-qqqx=1.asp

The world is unprepared for a flu pandemic, health officials said at a conference in Malaysia, citing a lack of political commitment, funding and a vaccine to protect humans against bird flu.

Without a vaccine against the deadly H5N1 strain, there’s no way of protecting billions of people who would be at risk should a pandemic start soon, officials from the US, UK and World Health Organisation (WHO) said at the International Congress on Infectious Diseases in Kuala Lumpur.

“We are a long way from being fully prepared,” Julie Gerberding, director of the US Centres for Disease Control and Prevention told reporters. “We do not have a vaccine that will provide universal protection, we do not have surveillance in every country, we do not have control of the virus in the animal reservoirs, and we have huge gaps in our basic understanding of influenza.”
 

JPD

Inactive
Toronto firm joins Chinese to combat flu

http://www.torontosun.com/News/TorontoAndGTA/2008/06/24/pf-5968146.html

$200M vaccine plant being built
By KWOK WONG, SUN MEDIA


A Toronto biotechnology company and China's Hunan province have embarked on a multi-million-dollar joint-venture that could make strides in preventing a flu pandemic.

Microbix's influenza vaccine-making process -- which uses chicken eggs to cultivate the vaccine -- is being transported to a $200-million factory in the southern Chinese province.

It will be one of the largest such facilities in the world, according to Mark Cochran, the lead director of Microbix.

"We are hoping it'll have a major impact, maybe even in preventing a pandemic," Cochran said at a news conference at The Exchange Tower, at King and York Sts.

PANDEMIC STRAIN

"Particularly in China, which is a flashpoint for the flu virus, to have protection there you will limit the antigenic drift and shift that could produce a pandemic strain.

"You're going after the problem, at the source."

Microbix and the Hunan governments are splitting the cost of the project.

Slated to be completed by 2013 in the city of Changsha, the factory will also house a chicken farm, and a full-scale replica of Dr. Norman Bethune's childhood home in Gravenhurst -- a gift from Microbix to a country where primary school children have textbooks dedicated to the World War II doctor.

PROTECTING PEOPLE

"He has and always will be remembered by the people of China," said Zhu Taoying, Consul-General of China, who added the new facility "will allow China to better meet the needs of its people both in combating seasonal flu and in protecting the population in the event of a pandemic."

The flu vaccine produced in the Chinese factory will have to receive regulatory approval from countries such as Canada before shipments can be sent beyond China's borders, said Cochran.

Yesterday marked the first step in "a journey of a thousand miles," he said. "Today we have taken a very big step."
 

JPD

Inactive
H5N1 Rostov Rook Matches Poultry and Wild Birds

http://www.recombinomics.com/News/06240803/H5N1_Rostov_Rook.html

Recombinomics Commentary 23:37
June 24, 2008

Full sequences from a rook, A/rook/Rostov-on-Don/26/2007, linked to the December, 2007 outbreak at Gulyay-Borisovskaya in Rostov was released at Genbank. The sequences were virtually identical to earlier sequences from the outbreak (A/chicken/Rostov-on-Don/35/2007, A/pigeon/Rostov-on-Don/6/2007, A/muscovy duck/Rostov-on-Don/51/2007, A/starling/Rostov-on-Don/39/07), which were made public four months ago. The delay in the release of the rook sequences may reflect lower levels of RNA in the rook isolates, leading to technical issues.

The outbreak was recently described in a presentation by Victor Irza on April 9. 2008 in Brussels on H5N1 in Russia, which included details showing the sequence of infections at the farm, as well as the locations of 7 dead birds in the city, and 7 positive cloacal swabs (see satellite map).

Included were pictures of rooks surrounding the farm, raising the possibility that the rooks were the source of the H5N1. The match in the sequences that were just released demonstrated the identity between the rooks sequence and other wild birds and poultry associated with the outbreak.

The identity in the multiple isolates from multiple wild bird species demonstrates how well sequences are conserved when the are linked to a common source. This level of identity is in marked contrast to difference between sequences from multiple locations within a country, such as the H5N1 sequences from Germany over the summer, as well as sequences collected in the Czech Republic. The differences demonstrate independent wild bird introductions, which were also seen in the sequences from the mute swans at the swannery in England. Although the report on that outbreak suggested the H5N1 was from a common source, the sequence diversity clearly indicated that the H5N1 was from multiple sources and was endemic to the wild swan population in the area.

The data from the rook also raise the possibility that H5N1 carriers, which can readily cause H5N1 in a variety of wild bird and domestic poultry species, can be infected at RNA levels which are near the limits of detection.
 

JPD

Inactive
Birds Deaths on Russia Islands Near Japan

http://www.recombinomics.com/News/06240802/Birds_Kunashir.html

Recombinomics Commentary 19:42
June 24, 2008

"On the territory of Sakhalin Region completed its first phase of monitoring studies of influenza and migratory bird species sinatropnyh. The research was carried out on the islands of the Lesser Kuril ridge and the island of Kunashir. Such a complicated expedition was undertaken in connection with the discovery at Cape Notsuke (father of Hokkaido) killed birds, vysokovirulentnym affected by influenza A virus subtype H5 N1 ", - said sobesednitsa Agency.

According to her, management specialists Rosselhoznadzora Research Institute of Virology and RAMS conducted comprehensive arrangements for the shooting and laboratory analysis of material extracted. On the territory of the Russian island signs of dead or sick birds were found.

The above translation describes H5N1 testing on Russian islands just north of Hokkaido, where H5N1 has been confirmed previously (see satellite map). Closely related H5N1 has also been detected in southeastern Russia as well as South Korea. The H5N1 in Japan was in whooper swans, which migrate to the north for the summer.

Like the excessive poultry deaths on Komchatka, thus far the testing has not produced confirmation of H5N1, but the location of the dead or sick birds raises concerns that the Fujian strain of H5N1 is migrating north along the East Asian flyway, which links to Alaska.

More results on these dead and dying birds would be useful. Samples from Kamchatka have been sent to Moscow for further analysis.
 

JPD

Inactive
Fears of pandemic remain despite progress combating avian influenza

http://mediaglobal.org/article/2008...in-despite-progress-combating-avian-influenza



By Shipra Prakash

24 June 2008 [MEDIAGLOBAL]: Even as Dr. David Nabarro, the United Nations System Influenza Coordinator, was speaking to a group of correspondents at the UN Secretariat about the improvements and remaining challenges in combating avian influenza, the Indonesian Health Ministry reported the deaths of two women from bird flu. Indonesia has had more human bird flu infections than any other country, with 110 deaths out of 135 cases.

Nabarro said that many countries had improved the functioning of veterinary services and bio-security in the rearing of poultry.

He commended the United Kingdom and the Republic of Korea for their quick and successful responses to bird flu outbreaks. But other countries have not been able to achieve similar results.

Nabarro pointed out that in 2008 there have been outbreaks among poultry in Indonesia, Vietnam, Bangladesh, Egypt and to a degree, Nigeria, although the situation in Nigeria had improved in recent months.

The Food and Agriculture Organization (FAO) reported in March that Indonesia is the country hardest hit by avian influenza.

With 20 percent of the country’s 1.4 billion chickens raised in backyards—the place where some 30 million Indonesian households raise poultry for food or income—special attention to the disease is warranted.

“Indonesia is facing the highest number of H5N1 cases in poultry,” Erwin Northoff, a spokesperson for the FAO, told MediaGlobal. H5N1 is the name of the virus that causes avian influenza.

But humans are being affected as well, according to Joseph Domenech, FAO Chief Veterinary Officer.

“The human mortality rate from bird flu in Indonesia is the highest in the world and there will be more human cases if we do not focus more on containing the disease at source in animals,” he said.

“The major challenge is to immediately apply the main components of a successful national avian influenza control strategy, based on effective surveillance, emergency culling and compensation, vaccination, improved biosecurity, effective laboratory and quarantine procedures, and movement controls of poultry and poultry products,” Domenech added.

According to Nabarro, much past human suffering can be attributed to the animal kingdom. Yellow fever originated in monkeys; HIV/AIDS began in a simian species and the respiratory disease SARS was believed to have come from bats, he said.

Armed with this knowledge, health officials in recent months have been drawing on the bird flu experience to analyze other diseases that could affect humankind. With the ‘One World, One Health’ initiative, UN agencies have been acting to bring veterinary professionals, human health experts and ministries of agriculture together with livestock departments.

Such projects are aided by the fact that funds received by the UN are not earmarked for any particular sector. National governments have pledged $2.7 billion in the past three or four years for the purpose of fighting outbreaks, and these funds can be used for both humans and animals, Nabarro said. On the human side, the funds have been used to build up the capacities of health systems to ensure better surveillance and faster, more comprehensive responses.

On the subject of treating infected humans, there is the question of whether a one-drug strategy will be effective.

A study published in the journal Nature in May revealed that no single drug would be sufficient to handle a global flu pandemic because the H5N1 virus is shown to be developing resistance to the leading anti-viral drug, Tamiflu.

The flu neuraminidase (N1) releases the virus from infected human cells, spreading the disease. Tamiflu and another drug, Relenza, restrain neuraminidase and so restrict the movement of the virus.

When a team at the National Institute for Medical Research (NIMC) — which is largely supported by the Medical Research Council (MRC) —used X-ray crystallography, a mutation in N1 was found, which has also been found in human incidences of H5N1.

The team discovered that when this mutation occurred the virus became resistant to Tamiflu, although it was still affected by Relenza.

“It is evident that a single drug has severe limitations,” Dr. Alan Hays, Director of the World Influenza Centre at NIMC and one of the authors of the study, told MediaGlobal.

The leading author of the study, Dr. Steve Gamblin, said “in order not to be outflanked by the virus, it will be necessary to have stockpiles of both drugs.”

“There is a huge imperative to develop further drugs and it is likely a future pandemic will need to be tackled using a three or four-pronged approach, much as we tackle HIV today,” he added.

Dr. Rupert Russell, a Lecturer at the UK-based University of St. Andrews’ School of Biology and another author of the study, agreed with Gamblin on the issue of stocking both drugs.

“I feel there is a need to stockpile both Tamiflu and Relenza, as there are growing concerns of Tamiflu-resistant viruses,” he told MediaGlobal.

Stocking both drugs could prevent large numbers of deaths. As the saying goes, it is better to be safe than sorry.
 

JPD

Inactive
Swabi Poultry Association says H5N9 mistaken for H5N1

http://www.dailytimes.com.pk/default.asp?page=2008\06\26\story_26-6-2008_pg7_53

SWABI: Swabi Poultry Association (SPA) on Wednesday staged a protest demonstration against District Livestock and Dairy Development Department and National Research Institute (NRI), Islamabad, for what they called ‘mistaking an H5N9 strain for H5N1’ that caused bird flu.

The authorities had detected H5N1 strain at a poultry farm in Swabi three days ago and ordered immediate closure of the farm and culling of 2,000 birds. The association’s office-bearers said that they had conducted their own test at the Poultry Research Institute (PRI), Rawalpindi, where the strain was identified as H5N9. The association’s president, Zabiullah, demanded that the government constitute an impartial committee that should take samples for fresh tests. He warned that if the government failed to listen to their demand till June 30, they would hold a hunger strike camp in front of the NWFP Assembly.
 

JPD

Inactive
Bird flu: Mexico prohibits poultry imports from Arkansas

http://www.straitstimes.com/Latest+News/World/STIStory_251880.html

MEXICO CITY - MEXICO is banning poultry imports from Arkansas because of a bird flu outbreak in the US state.

The Agricultural Department says poultry meat, fertilized eggs, song birds and messenger pigeons are banned indefinitely.

Avian influenza cases led to the destruction of 15,000 hens in western Arkansas earlier this month. The virus strain was not harmful to humans.

Mexico is a major market for US chicken. The US Agriculture Department says Mexico imported some 200,500 metric tons of chicken products in 2007. -- AP
 

JPD

Inactive
Baxter develops bird flu vaccine

Made near Prague, vaccine causes strong immune response

By Claire Compton
Staff Writer, The Prague Post
June 25th, 2008 issue

RENÉ JAKL/THE PRAGUE POST
By using cell cultures instead of hen eggs, Baxter was able to cut vaccine production time in half.

The H5N1 bird flu, first discovered in 1996, has killed 241 people in the past decade, with most fatalities in Asia and none in Europe

Scientists fear that the flu could mutate and more easily pass between humans, creating a pandemic

In 2006, several wild swans were the first domestic birds found to be infected with H5N1

The solution to a potential avian flu pandemic can be found approximately 30 kilometers outside of Prague, in Bohumile.

A production facility there owned by the U.S. biotech firm Baxter International is producing a vaccine, Celvapan, which has found success by deviating from the norm. To create the vaccine, Baxter’s scientists used monkey cells, rather than the traditional method of using hen’s eggs.

The advantage is in the consistency and high output of the cells. Hen’s eggs can cause logistical difficulties, requiring lots of advance planning. And during an epidemic, the birds would be at the mercy of the very same disease that the vaccine aims to combat.

“What we saw in Hong Kong was large-scale culling of birds [during outbreaks], so of course the supply of eggs becomes a concern,” said Hartmut Ehrlich, vice president for global research and development for Baxter Bioscience.

Erlich, along with Markus Müller, coauthored a paper on the vaccine’s trials that appeared in the June 12 edition of the New England Journal of Medicine, one of the world’s most prominent medical journals. The vaccine recently completed its phase I/II safety trial, which involved 250 people. The article reported a strong immune response in subjects who received the vaccine twice.

In addition to its culture method, the vaccine also makes no use of adjuvants, a component of most vaccines that boosts immune response but also causes many side effects.

Celvapan targets divergent strains of H5N1 virus, the flu that first passed to humans in Hong Kong a decade ago, killing six people. According to the World Health Organization (WHO), the avian flu has killed 241 of 383 cases since the Hong Kong outbreak, giving it a 63 percent fatality rate.

While the flu has presented itself primarily in Southeast Asia, there is global concern of a pandemic should the virus mutate, allowing it to transmit from human to human more easily.

“If you speak to experts within the WHO or within the ministries of health of various countries, there’s a lot of concern in this direction, and that’s why some countries have already decided to buy the vaccine directly from us or buy manufacturing capacity for them in the case of a pandemic,” Ehrlich said.

The United Kingdom has already been one such country to purchase the vaccine, and Ehrlich said the Czech government has been in talks with Baxter as well.
While the last flu season didn’t show the sort of outbreaks that have worried health officials in the past, it is impossible to predict whether the virus will mutate into a more virulent form in the future, Ehrlich said.

“Last winter we didn’t see birds containing the virus falling from the sky, but the virus is still incubating in Southeast Asia,” he said. “It hasn’t happened yet, but the fear is that a virus could be generated that jumps easily from human to human. For a pandemic to occur that would need to happen.”

The whole virus

Baxter opened its manufacturing operations in Bohumile in 2001 exclusively for the cell-culture production of its avian flu vaccine. The facility, one of the largest cell-culture vaccine production facilities in the world, had an initial investment of $70 million (1.1 billion Kč) and employs 230 people.

After years of readying the lab, it was licensed to manufacture the vaccine in 2005.

Baxter’s cell-culture method, which it is the first to use toward avian flu, has been employed for successful vaccines against other diseases such as polio and rabies. Ehrlich said the method has been developed for nearly 15 years, after a memorandum from the WHO urged researchers to pursue it.

The vaccine’s production time, a key part in preventing epidemics, is cut nearly in half with the cell-culture method, from 22–28 weeks using eggs to 12 weeks with cell cultures.

The process using hen’s eggs also has a different effect on the immune system because of how it is manufactured. The virus in the hen’s egg is treated with bleach and delivers a “disrupted” version of the virus.

The cell method delivers a “whole” version of the virus, and at a much lower dose. Because the immune system encounters the full version of the virus, it has an enhanced response. The added benefit of the method has meant that Celvapan worked against four different strains of the virus, whereas a hen’s egg vaccine would be limited only to the infecting strain.

Baxter’s next step has been a phase III study with 550 subjects, the data from which has not been fully analyzed yet. The results of all three studies are being process edfor an application for licensure from the European Medicines Agency, which Ehrlich expects to be approved this fall.
 

JPD

Inactive
Epidemic of Bird-Flu and HMFD

http://www.reliefweb.int/rw/RWB.NSF/db900SID/RMOI-7FY2DC?OpenDocument

North Korea Today No. 152 Jun 2008


“Research Institute for North Korean Society of Good Friends, in order to bring news of the food crisis in North Korea more accurately and quickly, will increase its e-newsletter frequency to more than one issue per week. As such, the release dates might shift. Thank you for your understanding and attention to this looming crisis. We at Good Friends hope to be a bridge between the North Korean people and the world.”

Epidemic of Bird-Flu and HMFD

Public Criticism on the Chickens Dying Even After Quarantine

Siniju Secures Preventive Measures against Bird-Flu

Executives at the Emergency Committee on the Epidemic Prevention Meet to Respond on the Epidemic of the Bird-Flu and the Hand-Foot-Mouth Diseases

Worries about Crop Damage Caused by Disease and Insects at Areas along the Border

Excluding Border-Crossers from the General Amnesty on the Occasion of Anniversary of Foundation of Korea Worker’s Party Criticized

Families Got Busy to Take Advantage of General Amnesty

[Epidemic of Bird-Flu and HMFD] Public Criticism on the Chickens Dying Even After Quarantine

Early June, officials from the Public Health department took preventive measures for livestock against bird-flu in Onsung County of North Hamgyung Province. However, chickens have begun to suffer and die from diarrhea, which has been raising public criticism regarding the measures. It is still unknown whether the chickens died from the measures or from another cause.

[Epidemic of Bird-Flu and HMFD] Siniju Secures Preventive Measures against Bird-Flu

Siniju is yet to experience any official outbreak of contagious diseases. However the city has been preparing for every possible preventive measure because it is constantly flowing with outside visitors and neighboring areas including Gangwon province have been already hit with the bird flu. There are signs saying, “Prevent Bird Flu,” or “Drink Boiled-Water,” on the door of each household. Public lectures have been given to educate residents to immediately report any outbreak of a contagious disease to the Emergency Committee on the Epidemic Prevention.

[Epidemic of Bird-Flu and HMFD] Executives at the Emergency Committee on the Epidemic Prevention Meet to Respond on the Epidemic of the Bird-Flu and the Hand-Foot-Mouth Diseases

June 18, a meeting was held at the Emergency Committee on the Quarantine of City of Chungjin, North Hamgyung province, for counter-measures against the ‘bird-flu’. Present at the meeting were the physicians of the Epidemics Prevention Centers at cities and counties where the bird-flu virus 71 was detected. At the meeting, criticisms were leveled against the physicians of the cities and counties where many children with two to seven years of age died of Hand-Foot-Mouth Disease and the counter-measures were discussed.

Gimchaek, North Hamgyung Province is the city where the most deaths from the HFMD occurred. A total of twenty two children died between April and June. Deaths in the other areas of North Hamgyung Province are seventeen at Chungjin, ten at Hoeryong and twelve at Musan. There are other areas from which unconfirmed deaths were reported. The Executives at the Emergency Committee on the Epidemic Prevention criticized those health officials in charge of the areas where the HFMD deaths occurred.
 

JPD

Inactive
Targeting an epidemic before it hurts

http://www.chinadaily.com.cn/china/2008-06/27/content_6800459.htm

Five years ago, an epidemic of the Severe Acute Respiratory Syndrome, better known as SARS, showed the authorities the benefits of transparency in reporting and handling a health crisis.

In a similar vein, this year's outbreak of hand, foot and mouth disease (HFMD) - which peaked at 11,501 daily reported cases on May 14 - has forced both central and local health authorities to find and plug loopholes in their surveillance of and response to epidemics.

HFMD can be caused by a host of intestinal viruses, but enterovirus 71 (EV71) is considered one of the more common ones that can cause a severe form of the disease.

The disease usually starts with a slight fever followed by blisters and ulcers in the mouth, and rashes on the hands and feet. Those affected by the EV71 often have serious symptoms, which can lead to meningitis, encephalitis, pulmonary edema and paralysis in some children.

HFMD itself is spread through direct contact with the mucus, saliva, or feces of an infected person.

EV71 is a frequent cause of HFMD epidemics associated with neurological disease in a small proportion of cases, the World Health Organization (WHO) has said.

HFMD cases, with a number having EV71 as the causative agent, hit 176,321 and including 40 fatalities - mostly involving children - on the Chinese mainland in May alone, the Ministry of Health reported.

Local Beijing health officials also warned this week that summer remains a peak season for HFMD.

The deaths of children from pneumonia-like symptoms first occurred in Fuyang, Anhui province, in late March.

The HFMD outbreak was confirmed and made public nationwide about a month later on April 27 - four days after the EV71 was identified in the cases.

By then, the number of recorded HFMD infections soared to more than 1,000 in Fuyang alone, including 20 fatalities.

The virus also spread to neighboring Henan province.

The sharp rise in the number of infections was mainly due to the fact that the virus spreads via routine contact, medical experts have explained. Infected adults can also pass on the virus to others, particularly children, even though they develop no serious symptoms other than rashes on hands.

"The longer people are kept in dark, the more likely they will get infected," said Yang Weizhong, the deputy chief of the Chinese Center for Disease Control and Prevention (CDC), adding that people can be caught unawares and not take any preventive measures.

Questions have been raised as to why it took so long for the public to be informed of the infectious disease. Although there is currently no vaccine available for the disease, measures such as hand washing and other ways of keeping personal hygiene have been known to be effective in guarding against the infection.

A number of contributing factors have been cited for the delay.

Before May 2, HFMD was not listed as an infection that had to be reported.

"It was beyond our scope to publicize the epidemic without accreditation from higher authority," said Wang Hao, spokesman for the Fuyang government.

Procedural delays were also cited.

The doctor who raised the alarm for the epidemic was pediatrician Liu Xiaolin, of Fuyang No 1 Hospital, after she saw two youngsters die "in front of my eyes, within hours", on the night of March 28.

Liu first attributed the deaths to lung infection, although the HFMD caused by EV71 is associated with neurological disease.

Upon receiving the death report from Liu on March 29, experts from the local Fuyang health bureau and the CDC immediately started lab work, discussions, and other research, to find out the definite cause of the deadly disease, said Yan Wei, deputy director of the Fuyang health bureau.

Meanwhile, the alert on what was known of the infection was sent out, but only to local hospitals to strengthen surveillance.

Yan and his colleagues had little to work on. Last year, a total of eight HFMD cases, including one adult, was reported in Fuyang.

"It must have been underreported, as the infection was not listed as one that had to be reported before May," said Ni Daxin, a leading researcher at the CDC.

Ni said no lab test had ever been taken in Fuyang to figure out the specific virus behind the disease.

Unable to pin down the cause of the latest outbreak in three days, Yan and his colleagues immediately turned to the provincial health authority, reporting the epidemic on March 31.

However, it took the provincial health authority another 14 days to report the outbreak to the Ministry of Health.

Above all, there was the difficulty of verifying the virus for a public dissemination of the health threat that was already overdue, said Yang from the CDC.

Feng Zijian, director of the emergency response department of the CDC, attributed the challenging verification process to complicated lab tests, which could take up a lot of time.

"In the initial stages of the probe, efforts were expended to rule out serious viral diseases like SARS, bird flu and meningitis," he said.

At that time, the CDC labs in most provinces already had the capacity for EV71 testing and confirmation.

"If you know you are looking for the EV71 virus, it takes a very short time to verify the virus; if you don't know and have a case in front of you of an unknown disease, of course it can take a month, or even longer," said WHO China Representative Hans Troedsson.

Yang Hui, who lives in the suburb of Fuyang and has a 4-year-old daughter and 2-year-old boy, still laments why it took so long for people like her to learn about ways to prevent HFMD.

"My boy was in the intensive care unit of the People's Hospital of Fuyang for nearly a week," she told China Daily on May 2, as she waited for the doctor to see her daughter who developed rashes on her hands at the hospital.

"If we were told earlier about the problem, even if the information was not accurate and detailed, I would not have delayed treatment for my boy and my girl might not have been infected," she said.

When Yang first learnt about EV71 on April 27 through a radio program, she received from the village clinic a thermometer, a bottle of disinfectant, and a brochure explaining how the viral disease can be transmitted simply through the sharing of eating utensils and how, in most cases, it can be prevented.

"That knowledge came too late," she said.

The early deaths from the viral infection were largely caused by delayed and improper treatment, themselves a result of ignorance of the illness, pediatrician Liu Xiaolin said.

HFMD is now listed with 37 other contagious diseases, including SARS, tuberculosis and HIV/AIDS, as a notifiable infection.

Cheng Xiaodong, a public health professor with Wuhan University, said that government agencies should learn to become more media savvy to publicize issues closely related to people's life and health, without delay and in a mutually accepted way.
 

JPD

Inactive
Maker of Tamiflu urges stockpiling

http://www.nj.com/business/ledger/index.ssf?/base/business-1/121454134052510.xml&coll=1

Fears of bird flu are receding and sales of the anti-flu drug Tamiflu have slumped.

Now, the drug's maker is offering a deal to American employers: Pay an annual fee and reserve enough to protect every worker if a new super-flu strikes.

The plan announced yesterday comes as the federal government also begins a new effort to encourage many businesses to stockpile anti-flu drugs in case of a pandemic. Those private stockpiles would supplement a national stockpile that contains enough doses to treat only a fraction of the population.

But stockpiling is a big upfront investment for a threat that may never arrive -- and requires replacing supplies whenever drug doses expire. Drugmaker Roche says its new plan would remove some of those barriers for companies otherwise interested in Tamiflu.

The U.S. government, in an unusual move, congratulated Roche on the program and helped to publicize it.

"We applaud them," said Tevi Troy, deputy secretary of the Department of Health and Human Services, which directs the nation's pandemic flu preparations. "Preparedness is a shared responsibility that extends across all levels of government and all levels of society."

Roche is a Swiss company whose U.S. operations are based in Nutley.

Pandemics can strike when the easy-to-mutate flu virus shifts to a strain that people have never experienced. There is concern that the Asian bird flu known as H5N1 might trigger one if it acquires the ability to spread easily from person to person.

It would take months to custom-brew a vaccine against a new super-flu. So the government has stockpiled enough antiviral drugs, mostly Tamiflu, to treat 50 million people, and is urging states to purchase enough for 31 million more.

The antiviral drugs also can be used to prevent infection before a vaccine arrives. Until recently, federal health officials didn't recommend employer stockpiling for fear there wasn't enough Tamiflu being produced to satisfy global demand during regular flu seasons, and built up the pandemic stockpiles of the U.S. and other governments.

But Roche increased global production 15-fold -- and U.S. guidelines proposed earlier this month not only say employer stockpiling is feasible, but also encourage businesses to set aside enough antiviral drugs to help their workers ward off infection and stay on the job.

"Businesses that provide goods or services essential to community health, safety, or well-being have an obligation to plan and prepare for continued operations in the event of a pandemic," the guidelines say.

Roche already has sold varying amounts of Tamiflu to more than 300 U.S. businesses, said George Abercrombie, chief executive of Hoffman-La Roche, the company's U.S. arm.

Under the new program, others companies could reserve Tamiflu instead of buying and storing it themselves. They would pay a yearly fee of $6 for every 10 capsules to be set aside in Roche storage and delivered within 48 hours of demand.

Upon delivery, companies would pay the going wholesale price. If a pandemic had begun, the price conceivably could spike. But Abercrombie rejected that as "a bit of a cynical view," adding, "that is not the way our company operates."
 

JPD

Inactive
Government ultimatum to chicken farmers:
Take our $1b or leave it!

http://www.thestandard.com.hk/news_detail.asp?pp_cat=30&art_id=67694&sid=19510753&con_type=1

The poultry industry has been given an official ultimatum accept a HK$1 billion government compensation package to shut down their businesses or face an uncertain future.

The city's 469 chicken retailers have been told they must decide what to do by July 24 while farmers, wholesalers and transport workers have been given until September 24.

Secretary for Food and Health York Chow Yat-ngok said this was the government's final offer after a meeting of the Executive Council yesterday.

As well as retailers, Hong Kong has 71 wholesalers, 50 chicken farms and 266 transport workers who depend on the trade for their livelihood.

However, if the retailers' accept the buyout deal it will effectively end the businesses of the rest of the sector as well as Hong Kong's culture of cooking live chickens.

The need for central slaughtering by 2011 may also be made redundant.

Chow expressed confidence that most of the retailers will accept the deal which is more than three times the 2005 Voluntary Surrender Scheme.

A lot of the traders said they can't operate under the overnight ban and they are also considering the risk of facing another bird flu outbreak within the next few years, he said.

But, the government will only approve the offer when 90 percent of the trade accepts it.

Another offer will not be tabled in the future before central slaughtering, Chow added.

A source said the government has improved the deal for retailers with an increase of almost HK$100 million or over 20 percent to a total of HK$513 million.

A source said the increase was justified.

"If we terminate the trade's tools for living out of public health concerns, we must be more reasonable in our offer," the source said, adding that no further increase is expected after any future negotiations.

Retailers who choose to resume operation on July 2 must operate under an overnight ban on keeping live chickens in the stalls between 8pm and 5am.

Violators are subject to a penalty of HK$50,000 and six months' imprisonment. The amendments of the law will be gazetted this week and will be tabled at the Legislative Council for negative vetting.

Chow believes the overnight ban will be agreed by lawmakers out of public health concerns.

"H5N1 is not political, we must be scientific in dealing with it," he said.

Chow said the 400,000 chickens which have been held in farms due to the ban and can no longer be sold because they are too old will be compensated for at a rate of HK$30 per bird.

A source said the government fears the recent discovery of the H5N1 virus in the chickens of four wet markets is not a problem of smuggling, but a drop in chickens' immunity against the virus.
 

JPD

Inactive
Slippery Slope of New Biology of Recombination in Influenza

http://www.recombinomics.com/News/06260802/Flu_New_Biology_Slippery.html

we found many sequences in the database that show very strong apparent evidence of homologous recombination. As a rough test for this, we divided the nucleotide sequence of each segment into two equal halves. For each pair of segments, we compared the number of nucleotide differences between them in the first half (i.e. 5’ in the positive strand) with the number of nucleotide differences in the second half. The idea is that if two segments are nearly identical in one part of their sequence, but very different in another part, this is strong evidence of homologous recombination, with the divergent parts explained by a recombination event.

The above comments are from the paper, “Anomalies in influenza genome database: New biology or lab errors?” Like an earlier paper, “Homologous recombination is very rare or absent in human influenza A virus”, the presence of sequences with clear cut recombination are acknowledged, but the papers try to link the examples to lab artifacts, suggesting re-sequencing of sequences with clear recombination, using the rationale that contaminated sequences will yield sequences with different cross-over points, which will reveal the contamination.

However, the sequence database includes similar sequences with matching crossover points, which provide a more rigorous proof of true homolgous recombination, because a lab artifact would require that all matching sequences are contaminated with the same sequences and the amplification process results in identical cross over points. Thus, these sequences alone would eliminate the issue of contamination.

In addition to multiple sequences that match, the database also has examples of re-sequenced samples, and the re-sequence result exactly matches the initial sequence. Thus, there are now many examples of homologous recombination which is not explained by sample contamination.

The cited sequences have dramatic examples of recombination between divergent sequences. However, template switching would be more common in sequences that are closely related and co-infections are more likely to involve closely related sequences. Thus, the presence of homologous recombination between distantly related sequences would support more frequent recombination between closely related sequences. These recombinations would appear as single nucleotide polymorphisms, which are linked to antigenic drift which is thought to be due to de novo mutations resulting from copy errors.

Examples of concurrent acquisition of the same polymorphism onto divergent genetic backgrounds, as well as aggregation of diverse polymorphisms into the same gene, provide examples of movement of single nucleotide polymorphisms via recombination, which serious challenges the basic tenet of influenza evolution.

Thus, the recent paper on recombination in avian and swine influenza, like the earlier paper on recombination in human influenza, signals the demise of the role of random mutations in rapid influenza evolution.
 

JPD

Inactive
Protection zone lifted

http://www.banburyguardian.co.uk/news/Protection-zone-lifted.4234095.jp

A PROTECTION zone put in place following an outbreak of bird flu at a Shenington farm has today been lifted.

Defra (Department for Environment, Food and Rural Affairs) had put in place the zone around Eastwood Farm following the H7N7 avian influenza outbreak on June 3.

Since then, active surveillance in the area has shown no evidence of disease spread and infection appears to be confined to the one infected premises.

Restrictions associated with the protection zone will fall, including the requirement to house birds but surveillance zone controls will instead apply.

Restrictions on bird gatherings and movements of poultry and poultry products are still in place, and keepers should maintain good biosecurity practices and report any suspicion of disease immediately.
 

JPD

Inactive
Mismatched H5N1 Vaccines Stockpiled By WHO?

http://www.recombinomics.com/News/06300802/H5N1_Vaccine_WHO.html

Recombinomics Commentary 11:38
June 30, 2008

we acknowledge your statement provided in your submission of April 5, 2007, that Sanofi Pasteur Inc. does not intend to license this product for commercial distribution, since it was produced under contract to the U.S. Department of Health and Human Services as part of national pandemic preparedness initiatives. Influenza Virus Vaccine, H5N1, is indicated for active immunization of persons 18 through 64 years of age at increased risk of exposure to the H5N1 influenza virus subtype contained in the vaccine.

Under this authorization you are approved to manufacture Influenza Virus Vaccine, H5N1 at your Swiftwater, PA facility. Final product filling, labeling, and packaging will be performed at your above facility. The vaccine will be supplied as a suspension in 5 mL multi-dose vials.

The dating period for Influenza Virus Vaccine, H5N1 shall be 18 months from the date of manufacture of the final container vaccine. The date of manufacture shall be defined as the date on which this monovalent vaccine is filled; thus, the 18-month shelf life is inclusive of the time that the product is held in filled final containers at 2-8oC prior to packaging.

The above comments, from the FDA approval letter for a pre-pandemic vaccine, raise questions about the disposition of a mismatched expiring stockpiled vaccine. As indicated, the vaccine was produced under a US HHS contract and therefore is not for distribution. As also indicated, the vaccine has an 18 month shelf life from the manufacture date.

This vaccine was targeted against clade 1 H5N1 from a patient in Vietnam in 2004. The early vaccines have marginal activity against the immunizing target in healthy young adults. The vaccine has limited cross reactivity with clade 2 which is the current clade causing virtually all reported human H5N1 infections. Since most of the vaccines that have gained regulatory approval were developed under programs that began several years ago, virtually all have clade 1 targets, including the US vaccine discussed above, as well as the vaccine in Japan, which is being discussed for use in first responders, which is likely linked to the recent clade 2.3.2 outbreaks in Japan, South Korea, and southeastern Russia. This Fujian strain was isolated from dead whooper swans in northern Japan, raising concerns that the Fujian strain, which is widespread in southern China and southeast Asia, will significant expand its global reach via the east Asian flyway, which links into North America via Alaska.

Recent results however, indicate the clade 1 vaccine can prime the immune response for subsequent booster shots given 1 to 1 ½ years after the initial two shots. Thus, these expiring pre-pandemic vaccines may have utility if used prior to the expiration. Recently, Sanofi Pasteur and GlaxoSmithKline have announce plans to ship 110 million vaccine doses (for vaccination of 55 million people) to the WHO for stockpiling for use after a pandemic begins.

However, the limited shelf life of a pre-pandemic vaccine, coupled with weak activity and significant mismatches, raises serious concerns about the value of such an approach to those who receive the vaccine, or the development of a vaccine against an emerging H5N1 which is being treated with a poorly matched vaccine.

These plans to stockpile weak mismatched vaccines may be hazardous to the world’s health.
 

JPD

Inactive
Pandemic H5N1 Vaccination With Heterologous Boosters

http://www.recombinomics.com/News/06300801/H5N1_Vaccine_Heterologous.html

Recombinomics Commentary 10:06
June 30, 2008

The first two contained a vaccine against the Vietnam strain of bird flu and the most recent was against the Indonesian strain.

The above comments from a reporter in the UK describing his participation pandemic vaccine clinical trials describe approaches being used by a number of companies. The earliest trials, which are now resulting in regulatory approval, started with one of two targets from patients in Vietnam infected in 2004. Both targets were clade 1, which was prevalent in southeast Asia in 2004/2005, when these trials began.

However, virtually all trials produced borderline results, even though the target population was healthy young adults, those most likely to respond positively. Although there was some cross reactivity with clade 2 isolates, which are linked to almost all current reported H5N1 human infections, the cross reactivity was lower than values for the homologous target. Thus, protection against an emerging H5N1 is questionable, since each clade 2 sub-clade has evolved markedly since 2005, and many of these sub-clades have produced fatal infections in humans.

Consequently, several companies are offering boosters to those who participated in the first trial, and the boosters generally are clade 2 isolates, like the clade 2.1 target described above. Recent results presented in Kalua Lumpur indicated that the boosted patients had higher titers against the original clade 1 target, as well as the clade 2 target used in the boost. These boosters were given 1 to 1½ years after the initial set of two immunizations.

The above data raises serious questions about the widespread plans to stockpile vaccines. The first vaccines were approved in the US over a year ago, and these vaccines have a shelf life of 18 months. Thus, in the next several months, these vaccines will expire. Although the vaccines will have offered some insurance for a pandemic that may have happened in the recent past, the discarded vaccines will have no value going forward. Only the small number of patients participating in the trials will have benefits from the formulations using clade 1 targets.

However, the protocol of using the earlier targets as an initial vaccination, followed by boosters using more recent isolates appears to be the most effective method for the generation of more respectable titers, which will have a greater likelihood of providing protection against future H5N1 targets.

Thus, the best use of these expiring vaccines would be to provide initial protection, followed by boosters at future dates. These mismatched vaccines will be best used at the present time. The current plan, which is to stockpile these mismatched vaccines for use after a pandemic begins will likely drive the evolution away from existing or emerging versions of H5N1 and decrease the likelihood of success for vaccines targeting the emerging strain.

Thus, the optimal use of the stockpile vaccines was immunization after earlier regulatory approval, which was done for a small number of patients enrolled in trials. The next best use would be to vaccinate now, before H5N1 is efficiently transmitted in human populations.

Stockpiling mismatched vaccines is likely to produce results which are far from optimal, and will likely produce significant problems related to the efficacy of future vaccines.
 

JPD

Inactive
SKorea lifts bird flu restrictions

http://ap.google.com/article/ALeqM5jqd0PwdV581qJ3D48kXRHzrZWxvQD91K9HI81

SEOUL, South Korea (AP) — South Korea said Monday it has lifted all special restrictions imposed to prevent the spread of bird flu after a series of recent outbreaks.

The Agriculture Ministry said in a statement it has slaughtered about 8.5 million birds to combat outbreaks of the disease that began in early April.

However, the ministry said no new outbreak has been found since May 12, and that as of Sunday it has lifted all special quarantine measures, such as restrictions on the movement and sale of poultry.

South Korea hopes to proclaim itself free of the disease in mid-August and report it to the World Organization for Animal Health, according to the ministry. Under the organization's regulations, a country can officially declare itself free of the disease if no new cases of bird flu have been found for three months.

Bird flu hit South Korea in 2003 and 2006, resulting in the killing of millions of chickens, ducks and other poultry.

The ministry said it suspected this year's bird flu outbreak was caused by migratory birds or foreign workers and tourists who visited China or Vietnam.

The virus remains hard for people to catch, but scientists worry it could mutate into a form that spreads more easily between humans, with the potential to kill millions worldwide. South Korea has reported no human infections of the H5N1 strain of bird flu that has killed 243 people elsewhere in the world, according to the World Health Organization.
 

JPD

Inactive
Pacific Rim Prepares For New Avian Flu

http://www.postchronicle.com/news/science/article_212155456.shtml

The governments of Japan, China and South Korea are making joint preparations in the event of an outbreak of a new strain of avian flu.

The three nations plan to conduct drills to determine whether information sharing and quarantine measures planned will be sufficient to deal with such an occurrence, The Yomiuri Shimbun reported Monday.

The H5N1 avian influenza virus is said to have mutated into a new strain that can be passed on to humans.
 

JPD

Inactive
Japan, China, S Korea to hold joint drill for new flu outbreak

http://www.japantoday.com/category/...orea-to-hold-joint-drill-for-new-flu-outbreak

TOKYO —

Japan, China and South Korea plan to hold a joint drill around October to better deal with a possible outbreak of a new strain of influenza, government sources said Monday.

The participants hope to share information and enhance cooperation through the first such drill among the countries, they said. A new flu is feared to break out in Asia through mutation of the bird flu virus.
 

JPD

Inactive
VIETNAM: Mekong Delta Farmers on Bird Flu Alert

http://www.ipsnews.net/news.asp?idnews=43014

CAN THO, Vietnam, Jun 30 (Newsmekong) - The bustling city of Can Tho is the capital of southern Vietnam’s fertile Mekong Delta and one of the country’s two main rice baskets. Good food in abundance makes it an ideal place to raise ducks and chickens, but this also means it is also one of the most high-risk areas in the country for bird flu.

While new outbreaks of the disease threaten the entire country, as harvest season gets underway officials are urging farmers in the Delta to be particularly vigilant.

"This is the time of the year when the whole of the Mekong Delta should keep our wits about bird flu," Nguyen Trong, a senior official in Can Tho’s Department of Agriculture and Rural Development and a member of the local Bird Flu Control and Prevention Office, said in an interview.

Three new outbreaks of bird flu have already been recorded in the Delta since early May.

Vietnam has recorded some significant results in its battle with the deadly bird flu virus. A prototype vaccine for the H5N1 virus is currently being tested and could be ready for local use by next year.

Bui Ba Bong, deputy minister of agriculture and rural development, told the National Steering Committee for Prevention and Control of Bird Flu in Hanoi that despite the good news, "bird flu epidemics from poultry remain a threat" often due to inadequate preventative measures.

Since January, the Ministry of Health has been training rapid-response teams throughout Vietnam and provided them with H5N1 virus-proof masks and protective suits.

"The human factor remains a key issue," Bong said. "A new relapse of bird flu is only possible if authorities neglect their responsibility."

Local media across the country have reported truckloads of poultry passing unchecked at quarantine stations. Dead fowl have also been found thrown carelessly into rice fields and waterways at the first sign of outbreaks.

"Some farmers have become so reckless that they refuse to vaccinate their fowl," said Nguyen Huy Nga, head of the Department for Preventive Medicine and Environment in the Ministry of Health in Hanoi.

As the harvest seasons gets into full swing, Nga believes it is especially important for authorities in the Mekong Delta to keep a close eye on potential outbreaks of avian influenza. "The situation could become worse during harvest season when poultry flocks are released into crop fields for food," he said.

Most farmers throughout the Mekong Delta use natural methods to raise ducks. Large quantities of ducks are released into newly harvested fields to pick at left over grains. Chickens are allowed to roam free in gardens. Farmers also drive large flocks of ducks from province to province to sell at big cities.

"The reality is that recent bird flu outbreaks in the Mekong River Delta were found among illegally incubated chicken and ducks that had not been vaccinated [against bird flu]," said Trong.

"For a long time we forgot about bird flu, and thus were taken by surprise when there were new outbreaks," said Dang Hanh, a farmer in Thot Not commune, Can Tho province. He said he had had to cull nearly 500 ducks and chickens due to recent outbreaks of the disease.

Many other villagers in the Delta reported a similar slackening in regard to preventive measures aimed at preventing bird flu.

Another part of the problem is the lack of attention paid by officials in the past to small-scale farmers. "Vaccinating teams do not come to our homes to vaccinate because we have not got many ducks and chickens," said Hanh. "If you want your birds to get vaccinated you must carry them to veterinary stations. This is an expensive and time consuming process small farmers like us want to avoid."

In response, Can Tho’s Bird Flu Control and Prevention Office has set up inter-provincial quarantine stations to tighten security, particularly in relation to small farms.

Many large-scale poultry farms in the Delta have been spared from the recent spread of avian flu due to a new method of raising birds developed by a Thai company, CP. Chickens are kept in self-contained coops equipped with cooling systems to provide a regulated temperature. These are adjusted according to each type and age of chicken.

"The fresh living environment shelters chickens from pathogens such as the H5N1 virus and thus protects them from the epidemic," said Vo Van Thach, owner of the biggest poultry farm in Can Tho province -- worth 1.2 billion Vietnamese dong (71,000 U.S. dollars).

Each province in the Mekong Delta now has between 100,000 and 450,000 chickens being raised according to this model, and there are plans to expand it.

"I also want my poultry to be raised like that, but there will be too much investment for me," Hanh from Thot Not commune said. For the time being, breeding fowls in the traditional way remains the sole option for small farmers, making them the first to be affected by bird flu when there is an outbreak.
 

JPD

Inactive
Bird flu virus 'unlikely to reach Australia'

http://www.abc.net.au/news/stories/2008/07/01/2290851.htm

An international conference in Brisbane has been told that it is unlikely a deadly strain of the bird flu virus will ever reach Australia.

It is the first time Australia has hosted the World Poultry Congress, with more than 2,000 delegates attending the first day.

Immunologist and Nobel prize-winner Peter Doherty says although the deadly H5N1 bird flu strain has killed 240 people overseas, Australia's dry climate and isolation will help prevent the virus entering the country.

"It's not something we have to worry about," he said.

But virus expert Dr Andrew Turner says there is still a slight risk.

"We have to be prepared, it may not be H5N1 which starts the pandemic - there are other viruses circulating in birds at the moment," he said.

However he says Australia's strict quarantine system is helping keep bird flu out of the country.

An inquiry into last year's horse flu outbreak blamed weak quarantine procedures for the spread of the virus.

Dr Turner says poultry is monitored more closely than horses.

"The restrictions on birds coming in, poultry genetics coming in, are much much stronger than horses," he said.

"It's a very strict quarantine regime and they come from birds in very highly protected flocks overseas."

The conference ends on Friday.
 
Top